THE EFFECT OF SODIUM-BUTYRATE ON THE GROWTH-CHARACTERISTICS OF HUMAN CERVIX TUMOR-CELLS

被引:12
作者
DYSON, JED [1 ]
DANIEL, J [1 ]
SURREY, CR [1 ]
机构
[1] COOKRIDGE HOSP, DEPT RADIOBIOL, LEEDS LS16 6QB, W YORKSHIRE, ENGLAND
关键词
D O I
10.1038/bjc.1992.172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sodium butyrate has been shown to affect cell proliferation, and, at concentrations above approximately 0.5 mM, to cause cell death in some tumour cell lines. When combined with cytotoxic drugs increase in chemosensitivity has been observed. We are presently carrying out a study of the combined effects of sodium butyrate and cytotoxic drugs on cultured cervix tumour cells. To provide a baseline for this study we have carried out a systematic investigation of the effects of sodium butyrate alone on the growth characteristics of cervix tumour cells cultured as multicell spheroids. This has shown that concentrations of n-butyrate of 0.005 mM to 0.50 mM decrease cell proliferation without inducing cell death, the effect increasing with increasing concentration. Butyrate concentrations > 0.50 mM cause cell death after a period of 5 to 15 days exposure, dependent on concentration. Concentrations of 0.010 mM and above cause fragmentation of, and increased cell shedding from, multicell spheroids, suggesting an effect on the cell surface. Concentrations of butyrate > 0.10 mM cause a considerable increase in the synthesis of cytokeratin, as shown by reaction with cytokeratin antibody. Correlated with this is a marked increase in cell size, concentrations of butyrate of 2.0 or 3.0 mM leading to an approximate doubling of cell diameter, followed by cell disintegration. The effects of butyrate < 0.25 mM are readily reversible. At concentrations > 0.25 mM the effects are reversible up to a limit of about 7 to 20 days depending on concentration, even when cytokeratin synthesis has been induced.
引用
收藏
页码:803 / 808
页数:6
相关论文
共 30 条
[11]  
GERDES J, 1984, J IMMUNOL, V133, P1710
[12]  
GERDES J, 1991, AM J PATHOL, V138, P867
[13]   FATTY-ACID CONTROL OF GROWTH OF HUMAN CERVICAL AND ENDOMETRIAL CANCER-CELLS [J].
GLEESON, RP ;
AYUB, M ;
WRIGHT, JT ;
WOOD, CB ;
HABIB, NA ;
SOUTTER, WP ;
SULLIVAN, MHF ;
WHITE, JO .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :500-503
[14]   CONCOMITANT PELVIC IRRADIATION, 5-FLUOROURACIL AND MITOMYCIN-C IN THE TREATMENT OF ADVANCED CERVICAL-CARCINOMA [J].
KHOURY, GG ;
BULMAN, AS ;
JOSLIN, CAF ;
ROTHWELL, RI .
BRITISH JOURNAL OF RADIOLOGY, 1991, 64 (759) :252-260
[15]  
KRUH J, 1982, MOL CELL BIOCHEM, V42, P65
[16]   CHANGES IN X-RAY-SENSITIVITY AND GLUTATHIONE CONTENT OF HUMAN-COLON TUMOR-CELLS AFTER EXPOSURE TO THE DIFFERENTIATION-INDUCING AGENT SODIUM-BUTYRATE [J].
LEITH, JT ;
HALLOWS, KT ;
ARUNDEL, CM ;
BLIVEN, SF .
RADIATION RESEARCH, 1988, 114 (03) :579-588
[17]   THE EFFECT OF BUTYRIC-ACID AND RETINOIC ACID ON INVASION AND EXPERIMENTAL METASTASIS OF MURINE MELANOMA-CELLS [J].
MCGARVEY, TW ;
SILBERMAN, S ;
PERSKY, B .
CLINICAL & EXPERIMENTAL METASTASIS, 1990, 8 (05) :433-448
[18]   CLINICAL-PHARMACOLOGY OF SODIUM-BUTYRATE IN PATIENTS WITH ACUTE-LEUKEMIA [J].
MILLER, AA ;
KURSCHEL, E ;
OSIEKA, R ;
SCHMIDT, CG .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (09) :1283-1287
[19]   BIOCHEMICAL AND ULTRASTRUCTURAL ALTERATIONS ACCOMPANY THE ANTIPROLIFERATIVE EFFECT OF BUTYRATE ON MELANOMA-CELLS [J].
NORDENBERG, J ;
WASSERMAN, L ;
PELED, A ;
MALIK, Z ;
STENZEL, KH ;
NOVOGRODSKY, A .
BRITISH JOURNAL OF CANCER, 1987, 55 (05) :493-497
[20]  
NOVOGRODSKY A, 1983, CANCER-AM CANCER SOC, V51, P9, DOI 10.1002/1097-0142(19830101)51:1<9::AID-CNCR2820510104>3.0.CO